Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS30017029HIVENSG00000065989.16protein_codingPDE4ANoNo5141P27815
TVIS30047835HIVENSG00000065989.16protein_codingPDE4ANoNo5141P27815
TVIS30047836HIVENSG00000065989.16protein_codingPDE4ANoNo5141P27815
TVIS30047837HIVENSG00000065989.16protein_codingPDE4ANoNo5141P27815
TVIS30047838HIVENSG00000065989.16protein_codingPDE4ANoNo5141P27815
TVIS30047839HIVENSG00000065989.16protein_codingPDE4ANoNo5141P27815
TVIS20020749HPVENSG00000065989.16protein_codingPDE4ANoNo5141P27815
TVIS20020750HPVENSG00000065989.16protein_codingPDE4ANoNo5141P27815
TCGA Plot Options
Drug Information
GenePDE4A
DrugBank IDDB06751
Drug NameDrotaverine
Target IDBE0001133
UniProt IDP27815
Regulation Typeinhibitor
PubMed IDs17502703; 12823389; 20554370
CitationsMuravyov AV, Yakusevich VV, Chuchkanov FA, Maimistova AA, Bulaeva SV, Zaitsev LG: Hemorheological efficiency of drugs, targeting on intracellular phosphodiesterase activity: in vitro study. Clin Hemorheol Microcirc. 2007;36(4):327-34.@@Romics I, Molnar DL, Timberg G, Mrklic B, Jelakovic B, Koszegi G, Blasko G: The effect of drotaverine hydrochloride in acute colicky pain caused by renal and ureteric stones. BJU Int. 2003 Jul;92(1):92-6.@@Pareek A, Chandurkar NB, Patil RT, Agrawal SN, Uday RB, Tambe SG: Efficacy and safety of aceclofenac and drotaverine fixed-dose combination in the treatment of primary dysmenorrhoea: a double-blind, double-dummy, randomized comparative study with aceclofenac. Eur J Obstet Gynecol Reprod Biol. 2010 Sep;152(1):86-90. doi: 10.1016/j.ejogrb.2010.05.007. Epub 2010 Jun 15.
GroupsApproved; Investigational
Direct ClassificationTetrahydroisoquinolines
SMILESCCOC1=C(OCC)C=C(C=C2/NCCC3=CC(OCC)=C(OCC)C=C23)C=C1
Pathways
PharmGKBPA165958398
ChEMBLCHEMBL551978